David R. Dills is a global regulatory affairs and compliance consultant with over 27 years of experience. He provides consultative services to medical device, biopharmaceutical, and other manufacturers. The document announces a two-day in-person seminar in Hong Kong on Good Clinical Practices (GCP) that Dills will conduct. The seminar will cover topics such as GCP principles and guidelines, clinical trial protocols, ethics requirements, and regulatory documentation and inspections. Attendees will include regulatory affairs specialists and auditors working in clinical research.